Insider Transactions in Q1 2024 at Centessa Pharmaceuticals PLC (CNTA)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2024
|
David M Chao Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,385
-3.66%
|
$114,235
$11.3 P/Share
|
|
Mar 31
2024
|
Tia L Bush Chief Technology & Quality Ofc |
SELL
Payment of exercise price or tax liability
|
Direct |
6,419
-3.64%
|
$70,609
$11.3 P/Share
|
|
Mar 31
2024
|
Iqbal J Hussain General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
7,520
-3.42%
|
$82,720
$11.3 P/Share
|
|
Mar 31
2024
|
Saurabh Saha Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
36,263
-4.01%
|
$398,893
$11.3 P/Share
|
|
Mar 31
2024
|
Gregory M Weinhoff Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,742
-4.24%
|
$129,162
$11.3 P/Share
|
|
Mar 25
2024
|
Karen M. Anderson Chief People Officer |
SELL
Open market or private sale
|
Direct |
51,160
-23.64%
|
$562,760
$11.94 P/Share
|
|
Mar 25
2024
|
Karen M. Anderson Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
45,000
+16.8%
|
$135,000
$3.93 P/Share
|
|
Feb 01
2024
|
David M Chao Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,503
-3.24%
|
$76,024
$8.19 P/Share
|
|
Feb 01
2024
|
David M Chao Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+11.35%
|
-
|
|
Feb 01
2024
|
Tia L Bush Chief Technology & Quality Ofc |
SELL
Payment of exercise price or tax liability
|
Direct |
3,862
-2.14%
|
$30,896
$8.19 P/Share
|
|
Feb 01
2024
|
Tia L Bush Chief Technology & Quality Ofc |
BUY
Grant, award, or other acquisition
|
Direct |
42,500
+19.07%
|
-
|
|
Feb 01
2024
|
Saurabh Saha Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
26,323
-2.83%
|
$210,584
$8.19 P/Share
|
|
Feb 01
2024
|
Saurabh Saha Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
144,200
+13.41%
|
-
|
|
Feb 01
2024
|
Gregory M Weinhoff Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,494
-3.99%
|
$91,952
$8.19 P/Share
|
|
Feb 01
2024
|
Gregory M Weinhoff Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,250
+9.78%
|
-
|
|
Feb 01
2024
|
Iqbal J Hussain General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
7,885
-3.46%
|
$63,080
$8.19 P/Share
|
|
Feb 01
2024
|
Iqbal J Hussain General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
42,500
+15.72%
|
-
|
|
Feb 01
2024
|
Karen M. Anderson Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,265
-8.55%
|
$58,120
$8.19 P/Share
|
|
Feb 01
2024
|
Karen M. Anderson Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,250
+26.89%
|
-
|
|
Feb 01
2024
|
Harris Rotman SVP Regulatory Affairs |
SELL
Open market or private sale
|
Direct |
4,267
-6.38%
|
$34,136
$8.1 P/Share
|
|
Feb 01
2024
|
Harris Rotman SVP Regulatory Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
4,108
-5.79%
|
$32,864
$8.19 P/Share
|
|
Feb 01
2024
|
Harris Rotman SVP Regulatory Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+34.56%
|
-
|